AI Algorithm Promises to Improve Workflows at Ohio Cancer Center
Pathologists at OSUCCC-James have been evaluating an AI algorithm for the past year. The results are extremely promising.
Read MorePosted by Chris Wolski | Jan 30, 2024 | Prostate |
Pathologists at OSUCCC-James have been evaluating an AI algorithm for the past year. The results are extremely promising.
Read MorePosted by Andy Lundin | Jan 29, 2024 | Unknown Origin & Other Cancer Types |
New research is guiding the development of blood tests to detect and monitor responses to therapies in neuroendocrine carcinomas patients.
Read MorePosted by Andy Lundin | Jan 22, 2024 | Prostate |
A new study has found that rectal examination has no advantages over the PSA blood test for detecting prostate cancer.
Read MorePosted by Andy Lundin | Jan 16, 2024 | Lung Cancer |
The epigenomic technology platform predicts and monitors immunotherapy responses for patients with non-small cell lung cancer (NSCLC).
Read MorePosted by Chris Wolski | Jan 12, 2024 | Digital Pathology |
By examining the UK’s technology-centric strategy and response, nations can right-size the practice of pathology and prepare for the future.
Read More